Sponsored
Please check back later for more content.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
NLX-112 Shows Safety and Tolerability in Phase 2a Parkinson Trial, Supporting Further Development
2
Using Subcutaneous Self-Administered Lecanemab for Alzheimer Disease: Robert Przybelski, MD, MS
3
Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome
4
Continuous Subcutaneous Infusion Pumps in Parkinson’s Disease
5